Literature DB >> 2653374

Immunogenetics of human cell surface differentiation.

W J Rettig1, L J Old.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2653374     DOI： 10.1146/annurev.iy.07.040189.002405

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN： 0732-0582            Impact factor:   28.527


× No keyword cloud information.
  20 in total

Review 1.  Specificity of antiglycolipid antibodies.

Authors:  N Baumann
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Monoclonal antibodies in cancer therapy.

Authors:  Andrew M Scott; James P Allison; Jedd D Wolchok
Journal:  Cancer Immun       Date:  2012-05-01

Review 3.  mRNA: A Novel Avenue to Antibody Therapy?

Authors:  Thomas Schlake; Moritz Thran; Katja Fiedler; Regina Heidenreich; Benjamin Petsch; Mariola Fotin-Mleczek
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

4.  Report from Vienna: in search of all surface molecules expressed on human leukocytes.

Authors:  E A Clark; L L Lanier
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

5.  Immunohistochemical analysis of LNT, NeuAc2----3LNT, and Lex carbohydrate antigens in human tumors and normal tissues.

Authors:  P Garin-Chesa; W J Rettig
Journal:  Am J Pathol       Date:  1989-06       Impact factor: 4.307

Review 6.  Antibody therapy of cancer.

Authors:  Andrew M Scott; Jedd D Wolchok; Lloyd J Old
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

7.  Antinuclear antibodies as potential markers of lung cancer.

Authors:  F Fernández-Madrid; P J VandeVord; X Yang; R L Karvonen; P M Simpson; M J Kraut; J L Granda; J E Tomkiel
Journal:  Clin Cancer Res       Date:  1999-06       Impact factor: 12.531

8.  Expression of the VLA beta 1 integrin family in bladder cancer.

Authors:  M Liebert; R Washington; J Stein; G Wedemeyer; H B Grossman
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  Prospects for gene-engineered T cell immunotherapy for solid cancers.

Authors:  Christopher A Klebanoff; Steven A Rosenberg; Nicholas P Restifo
Journal:  Nat Med       Date:  2016-01       Impact factor: 53.440

10.  Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.

Authors:  P Garin-Chesa; I Campbell; P E Saigo; J L Lewis; L J Old; W J Rettig
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.